Primary drug resistance and transmission analysis of HIV-1 in acute and recent drug-naive seroconverters in Singapore

被引:25
|
作者
Lee, C. C.
Sun, Y. J. [1 ]
Barkham, T. [2 ]
Leo, Y. S.
机构
[1] Tan Tock Seng Hosp, TTSH Med Ctr, Infect Dis Res Lab, Dept Infect Dis, Singapore 308433, Singapore
[2] Tan Tock Seng Hosp, Dept Lab Med, Singapore 308433, Singapore
基金
英国医学研究理事会;
关键词
HIV-1; molecular epidemiology; phylogenetics; primary resistance; seroconverter; IMMUNODEFICIENCY-VIRUS TYPE-1; TREATMENT-EXPERIENCED PATIENTS; HETEROSEXUAL TRANSMISSION; MOLECULAR EPIDEMIOLOGY; ANTIRETROVIRAL THERAPY; GENOTYPIC RESISTANCE; PRIMARY INFECTION; VIRAL LOAD; MUTATIONS; RISK;
D O I
10.1111/j.1468-1293.2009.00698.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives The aim of the study was to elucidate primary drug resistance and transmission of HIV-1 in acute and recent drug-naive seroconverters in Singapore. Methods Acute and recent HIV-1 seroconverters were enrolled in the study. The HIV-1 polymerase (pol) gene was sequenced and used for genotypic drug resistance analysis and phylogenetic analysis. HIV-1 transmission clusters were inferred from phylogenetic clustering analysis. Results Of the 60 subjects analysed, 95% were men, and 73.3% were men who have sex with men (MSM). Six HIV-1 subtypes were identified, including CRF01_AE (46.7%), subtypes B (30%), B' (15%) and G (1.7%), CRF33_01B (1.7%) and CRF34_01B (5%). Primary genotypic resistance was detected in only one (1.7%) subtype B variant. Thirty-one patients (51.7%) were phylogenetically clustered, of whom 90% reported having local risk exposure, compared with 59% of the patients who were not phylogenetically clustered [odds ratio (OR) 6.35, 95% confidence interval (CI) 1.65-23.95]. MSM (OR 5.63, 95% CI 1.17-27.15), high viral load (OR 4.28, 95% CI 1.37-13.36) and young age (OR 0.92, 95% CI 0.85-0.99) were independently associated with clustered individuals. Conclusions In Singapore, HIV-1 primary resistance is insignificant; individuals with seroconversion account for about half of onward transmission among recently infected seroconverters. MSM, high viral load and young age are factors that facilitate transmission. Early detection of these individuals is of paramount importance for the prevention of HIV-1 transmission.
引用
收藏
页码:370 / 377
页数:8
相关论文
共 50 条
  • [1] Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid
    Briones, C
    Pérez-Olmeda, M
    Rodríguez, C
    del Romero, J
    Hertogs, K
    Soriano, V
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 (02): : 145 - 150
  • [2] HIV-1 transmission dynamics in recent seroconverters: relationship with transmission of drug resistance and viral diversity
    Recordon-Pinson, P.
    Peuchant, O.
    Capdepont, S.
    Lavignolle, V.
    Neau, D.
    Morlat, P.
    Pellegrin, J. L.
    Thiebaut, R.
    Dabis, F.
    Fleury, H.
    Masquelier, B.
    [J]. ANTIVIRAL THERAPY, 2007, 12 (05) : S43 - S43
  • [3] Transmitted drug resistance among HIV-1 drug-naive patients in Greece
    Kantzanou, Maria
    Karalexi, Maria A.
    Papachristou, Helen
    Vasilakis, Alexis
    Rokka, Chrysoula
    Katsoulidou, Antigoni
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 105 : 42 - 48
  • [4] Update on transmission of HIV resistance to drug-naive patients in Argentina
    Petroni, A.
    Deluchi, G.
    Lopardo, G.
    Pryluka, D.
    Biscayart, C.
    Rotryng, F.
    Botas, A.
    Rodriguez Iantorno, P.
    Gatti, S.
    Soto, J.
    Benetucci, J.
    [J]. ANTIVIRAL THERAPY, 2010, 15 : A179 - A179
  • [5] Resistance profiles to antiretroviral drugs in HIV-1 drug-naive patients in Argentina
    Kijak, GH
    Pampuro, SE
    Avila, MM
    Zala, C
    Cahn, P
    Wainberg, MA
    Salomón, H
    [J]. ANTIVIRAL THERAPY, 2001, 6 (01) : 71 - 77
  • [6] Assessing transmissibility of HIV-1 drug resistance mutations from treated and from drug-naive individuals
    Winand, Raf
    Theys, Kristof
    Eusebio, Monica
    Aerts, Jan
    Camacho, Ricardo J.
    Gomes, Perpetua
    Suchard, Marc A.
    Vandamme, Anne-Mieke
    Abecasis, Ana B.
    [J]. AIDS, 2015, 29 (15) : 2045 - 2052
  • [7] Molecular epidemiology of recent seroconverters and drug-resistant HIV-1 transmission networks in Japan
    Hattori, J.
    Shiino, T.
    Sugiura, W.
    [J]. ANTIVIRAL THERAPY, 2014, 19 : A66 - A66
  • [8] Analysis of HIV-1 diversity, primary drug resistance and transmission networks in Croatia
    Maja Oroz
    Josip Begovac
    Ana Planinić
    Filip Rokić
    Maja M. Lunar
    Tomaž Mark Zorec
    Robert Beluzić
    Petra Korać
    Oliver Vugrek
    Mario Poljak
    Snježana Židovec Lepej
    [J]. Scientific Reports, 9
  • [9] Analysis of the Diversity of the HIV-1 pol Gene and Drug Resistance Associated Changes Among Drug-Naive Patients in Burkina Faso
    Tebit, Denis M.
    Sangare, Lassana
    Tiba, Fabrice
    Saydou, Yameov
    Makamtse, Aline
    Somlare, Hermann
    Bado, Guillaume
    Kouldiaty, Boris G.
    Zabsonre, Inoussa
    Yameogo, Sibiri L.
    Sathiandee, Kanokporn
    Drabo, Joseph Y.
    Kraeusslich, Hans-Georg
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (10) : 1691 - 1701
  • [10] Transmission of HIV-1 drug resistance
    Tang, JW
    Pillay, D
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2004, 30 (01) : 1 - 10